Citius Pharmaceuticals, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Citius Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $4.25 million for the year ending 2025.

  • Citius Pharmaceuticals, Inc. showed an increase of +30.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Citius Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on December 23, 2025.
  • XBRL data for this metric is available from 2010 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2014: $21.9 thousand | Q2 2014: $23.4 thousand | Q3 2014: $1.55 million | Q4 2014: $817.2 thousand | Q1 2015: $760.4 thousand | Q2 2015: $951.0 thousand | Q4 2015: $281.5 thousand | Q1 2016: $3.76 million | Q4 2016: $46.8 thousand | Q1 2017: $61.1 thousand | Q2 2017: $198.7 thousand | Q4 2017: $7.37 million | Q1 2018: $5.01 million | Q2 2018: $2.76 million | Q4 2018: $7.04 million | Q1 2019: $3.20 million | Q2 2019: $4.51 million | Q4 2019: $2.78 million | Q1 2020: $4.34 million | Q2 2020: $8.52 million | Q3 2020: $13.86 million | Q4 2020: $4.30 million | Q1 2021: $103.70 million | Q2 2021: $115.66 million | Q4 2021: $65.42 million | Q1 2022: $55.76 million | Q2 2022: $48.04 million | Q4 2022: $36.89 million | Q1 2023: $29.07 million | Q2 2023: $33.28 million | Q4 2023: $20.35 million | Q1 2024: $12.56 million | Q2 2024: $17.91 million | Q4 2024: $1.10 million | Q1 2025: $26.4 thousand | Q2 2025: $6.09 million | Q3 2025: $4.25 million | Q4 2025: $7.72 million.
  • Historical annual values: Fiscal year 2025: $4.25 million | Fiscal year 2024: $3.25 million | Fiscal year 2023: $26.48 million | Fiscal year 2022: $41.71 million | Fiscal year 2021: $70.07 million | Fiscal year 2020: $13.86 million | Fiscal year 2019: $7.89 million | Fiscal year 2018: $9.18 million | Fiscal year 2017: $3.20 million | Fiscal year 2016: $294.4 thousand | Fiscal year 2016: $1.63 million | Fiscal year 2015: $676.1 thousand | Fiscal year 2014: $1.55 million | Fiscal year 2013: $54.4 thousand | Fiscal year 2013: $0.00 | Fiscal year 2012: $41.7 thousand | Fiscal year 2012: $135.00 | Fiscal year 2011: $212.00 | Fiscal year 2010: $2.5 thousand | Fiscal year 2010: $0.00.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: